Pfizer, Inc. under full-scale attack

Starboard Value, which enters the scene with a billion-dollar stake in Pfizer, in other words less than 0.5% of the capital, is aiming straight for the head, demanding to see CEO Albert Bourla’s head rolled to the ground. The case smacks of a vendetta, as Starboard, advised and supported by former P…
© MarketScreener.com 2024